« About Botanical Crohns Treatments – they are appropriate?

Cadila receives approval for anti-diabetes molecule clinical study

Cadila gets permission for anti-diabetic molecule clinical trial
New Delhi, Jun 21 : Pharmaceutical firm Zydus Cadila today said the company has received permission from the drug controller for phase I clinical trial of its anti-diabetic molecule.

Read more on New Kerala

This entry was posted by admin on June 24, 2010 at 4:59 pm, and is filed under Health Conditions. Follow any responses to this post through RSS 2.0.You can leave a response or trackback from your own site.